Very long-term (15 to 20 Years) clinical and angiographic outcome after coronary bare metal stent implantation

Circulation: Cardiovascular Interventions

Volumn 3, Issue 5, 2010, Pages 468-475

  Yamaji, Kyohei ^a   Kimura, Takeshi ^b   Morimoto, Takeshi ^b   Nakagawa, Yoshihisa ^c   Inoue, Katsumi ^d   Soga, Yoshimitsu ^a   Arita, Takeshi ^a   Shirai, Shinichi ^a   Ando, Kenji ^a   Kondo, Katsuhiro ^a   Sakai, Koyu ^a   Goya, Masahiko ^a   Iwabuchi, Masashi ^a   Yokoi, Hiroyoshi ^a   Nosaka, Hideyuki ^a   Nobuyoshi, Masakiyo ^a  

^a KOKURA MEMORIAL HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TENRI HOSPITAL   (Japan)

^d KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Coronary artery disease; Prognosis; Restenosis; Stents; Thrombosis

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BARE METAL STENT; CAUSE OF DEATH; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STENT THROMBOSIS; SUDDEN DEATH;

ADULT; AGED; AGED, 80 AND OVER; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; STENTS; SURVIVAL ANALYSIS; THROMBOSIS; TIME FACTORS;

EID: 78650117789     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.110.958249     Document Type: Article

References (24)

1. Kimura T, Abe K, Shizuta S, Odashiro K, Yoshida Y, Sakai K, Kaitani K, Inoue K, Nakagawa Y, Yokoi H, Iwabuchi M, Hamasaki N, Nosaka H, Nobuyoshi M. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries. Circulation. 2002; 105:2986-2991. (Pubitemid 34693831)
2. van Domburg RT, Foley DP, de Jaegere PPT, de Feyter P, van den Brand M, van der Giessen W, Hamburger J, Serruys PW. Long term outcome after coronary stent implantation: A 10 year single centre experience of 1000 patients. Heart. 1999;82(suppl II):II27-II34. (Pubitemid 29469884)
3. Choussat R, Klersy C, Black AJR, Bossi I, Laurent JP, Jordan C, Guagliumi G, Fajadet J, Marco J. Long-term (≥8 years) outcome after Palmaz-Schatz stent implantation. Am J Cardiol. 2001;88:10-16. (Pubitemid 32553885)
4. Karam C, Fajadet J, Beauchet A, Cassagneau B, Marco J. Nine-year follow-up of balloon-expandable Palmaz-Schatz stent in patients with single-vessel disease. Cathet Cardiovasc Interv. 2000;50:170-174. (Pubitemid 30353840)
5. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, and on behalf of the Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation. 2007;115:2344-2351. (Pubitemid 46685903)
6. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: Advantages of a new specific activity scale. Circulation. 1981;64: 1227-1234. (Pubitemid 12236153)
7. Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, Sato Y, Yokoi H, Hamasaki N, Nosaka H, Nobuyoshi M. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med. 1996;334:561-566. (Pubitemid 26066129)
8. Inoue K, Abe K, Ando K, Shirai S, Nishiyama K, Nakanishi M, Yamada T, Sakai K, Nakagawa Y, Hamasaki N, Kimura T, Nobuyoshi M, Miyamoto TA. Pathological analyses of long-term intracoronary Palmaz- Schatz stenting. Is its efficacy permanent? Cardiovasc Pathol. 2004;13: 109-115. (Pubitemid 38366430)
9. Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y, Mizuno K. Appearance of lipid-laden intima and neovascularization after implantation of bare metal stents: Extended late phase observation by intracoronary optical coherence tomography. J Am Coll Cardiol. 2010; 55:26-32.
10. Guiteras-Val P, Varas-Lorenzo C, Garcia-Picart J, Marti-Claramunt V, Auge-Sanpera JM. Clinical and sequential angiographic follow-up six months and 10 years after successful percutaneous transluminal coronary angioplasty. Am J Cardiol. 1999;83:868-874. (Pubitemid 29143123)
11. Yamada T, Inoue K, Hamasaki N, Nakagawa Y, Iwabuchi M, Yokoi H, Kimura T, Nosaka H, Nobuyoshi M. Late restenosis of the balloon-dilated site: Serial angiographic observations beyond 7 years. Circ J. 2005;69: 380-385.
12. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R. Healed plaque rupture and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression. Circulation. 2001;103:934-940. (Pubitemid 32183797)
13. Nakazawa G, Vorpahl M, Finn AV, Narula J, Virmani R. One step forward and two steps back with drug-eluting-stents: From preventing restenosis to causing late thrombosis and nouveau atherosclerosis. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:625-628.
14. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202. (Pubitemid 43929240)
15. Goto K, Shiode N, Shirota K, Fukuda Y, Kitamura F, Tominaga K, Kato Y, Miura H, Inoue K, Nobuyoshi M. Pathological finding of sirolimuseluting stent (SES) restenosis lesion with black hole appearance on intravascular ultrasound. Circ J. 2009;73:1969-1971.
16. Nakagawa Y, Kimura T, Morimoto T, Nomura M, Saku K, Haruta S, Muramatsu T, Nobuyoshi M, Kadota K, Fujita H, Tatami R, Shiode N, Nishikawa H, Shibata Y, Miyazaki S, Murata Y, Honda T, Kawasaki T, Doi O, Hiasa Y, Hayashi Y, Matsuzaki M, Mitsudo K, for the j-Cypher Registry Investigators. Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent: Three-year follow-up of the j-Cypher registry. Am J Cardiol. 2010;106:329-336.
17. Doyle B, Rihal CS, O'Sullivan CJ, Lennon RJ, Wiste HJ, Bell M, Bresnahan J, Holmes DR Jr. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare metal coronary stents. Circulation. 2007;116:2391-2398. (Pubitemid 350145074)
18. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study. Lancet. 2007;369:667-678. (Pubitemid 46281313)
19. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K, j-Cypher Registry Investigators. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009;119:987-995.
20. Morice MC, Serruys PW, Barragan P, Bode C, Van Es GA, Stoll HP, Snead D, Mauli L, Cutlip DE, Sousa E. Long-term clinical outcomes with sirolimus-eluting coronary stents: Five-year results of the RAVEL trial. J Am Coll Cardiol. 2007;50:1299-1304. (Pubitemid 47454687)
21. Weisz G, Leon MB, Holmes DR Jr, Kereiakes DJ, Popma JJ, Teirstein PS, Cohen SA, Wang H, Cutlip DE, Moses JW. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus- Eluting Stent in De-Novo Native Coronary Lesions) Trial. J Am Coll Cardiol. 2009;53:1488-1497.
22. Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW, Schofer J, Morice MC, Schampaert E, Kirtane AJ, Popma JJ, Parise H, Fahy M, Mehran R. Five-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare metal stents. J Am Coll Cardiol. 2009;54:894-902.
23. Grube E, Dawkins K, Guagliumi G, Banning A, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Joshi A, Mascioli S. TAXUS VI final 5-year results: A multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions. EuroIntervention. 2009;4:572-577.
24. Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K, Stoll HP, ARTS II Investigators. Five-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol. 2010;55:1093-1101.